CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,658 | -12.7% | 15,283 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $204,597 | -12.6% | 15,223 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $234,226 | -3.1% | 14,127 | +8.7% | 0.00% | 0.0% |
| Q4 2022 | $241,800 | +99.8% | 13,000 | -24.7% | 0.00% | 0.0% |
| Q2 2022 | $121,000 | -15.4% | 17,275 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $143,000 | +19.2% | 17,275 | -2.1% | 0.00% | 0.0% |
| Q4 2021 | $120,000 | +27.7% | 17,652 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $94,000 | -6.9% | 17,652 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $101,000 | +27.8% | 17,652 | +3.2% | 0.00% | 0.0% |
| Q1 2021 | $79,000 | +38.6% | 17,109 | +0.6% | 0.00% | +100.0% |
| Q4 2020 | $57,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |